{"id":"https://openalex.org/W2906801530","doi":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","title":"Nivolumab versus nivolumab with ipilimumab versus trifluridine/tipiracil for metastatic microsatellite instability-high colorectal cancer: A modeling decision analysis.","display_name":"Nivolumab versus nivolumab with ipilimumab versus trifluridine/tipiracil for metastatic microsatellite instability-high colorectal cancer: A modeling decision analysis.","publication_year":2018,"publication_date":"2018-02-01","ids":{"openalex":"https://openalex.org/W2906801530","doi":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","mag":"2906801530"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.4_suppl.829","doi":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024082160","display_name":"Jacqueline N. Chu","orcid":"https://orcid.org/0000-0003-1290-1634","observed_orcids":["https://orcid.org/0000-0003-1290-1634"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline N. Chu","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017579044","display_name":"Jin Choi","orcid":"https://orcid.org/0000-0001-8517-8374","observed_orcids":["https://orcid.org/0000-0001-8517-8374"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin G. Choi","raw_affiliation_strings":["Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091817985","display_name":"Sassan Ostvar","orcid":"https://orcid.org/0000-0002-7034-9625","observed_orcids":["https://orcid.org/0000-0002-7034-9625","https://orcid.org/0000-0002-8908-1956"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sassan Ostvar","raw_affiliation_strings":["Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055927975","display_name":"James Anthony Torchia","orcid":"https://orcid.org/0000-0001-5291-8698","observed_orcids":["https://orcid.org/0000-0001-5291-8698"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A. Torchia","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035343389","display_name":"Kerry Lynn Reynolds","orcid":"https://orcid.org/0000-0002-7793-654X","observed_orcids":["https://orcid.org/0000-0002-7793-654X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry Lynn Reynolds","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081227348","display_name":"Justin F. Gainor","orcid":"https://orcid.org/0000-0001-8697-4081","observed_orcids":["https://orcid.org/0000-0001-8697-4081"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin F. Gainor","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086897381","display_name":"Daniel C. Chung","orcid":"https://orcid.org/0000-0001-8226-7005","observed_orcids":["https://orcid.org/0000-0001-8226-7005"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel C. Chung","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088474933","display_name":"Jeffrey William Clark","orcid":"https://orcid.org/0000-0001-9524-3600","observed_orcids":["https://orcid.org/0000-0001-9524-3600"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Clark","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055200350","display_name":"Chin Hur","orcid":"https://orcid.org/0000-0002-2819-7576","observed_orcids":["https://orcid.org/0000-0002-2819-7576"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chin Hur","raw_affiliation_strings":["Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210087915"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"4_suppl","first_page":"829","last_page":"829"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.1898999959230423,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.17419999837875366,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microsatellite-instability-high-colorectal-cancer","display_name":"microsatellite instability-high colorectal cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.972000002861023},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":0.9829999804496765},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.734000027179718},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9480000138282776},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9399999976158142},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7570000290870667},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.6660000085830688},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9251737594604492},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.852643609046936},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8525980710983276},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6335787773132324},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.6220257878303528},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5910230875015259},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5687877535820007},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4412347078323364},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1584336757659912},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.4_suppl.829","doi":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.4_suppl.829","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2896185064","https://openalex.org/W2892097487","https://openalex.org/W7211961922","https://openalex.org/W4416955340","https://openalex.org/W7202150332","https://openalex.org/W4200357127","https://openalex.org/W6939659436","https://openalex.org/W4408285353","https://openalex.org/W2758842849","https://openalex.org/W4404784379"],"abstract_inverted_index":{"829":[0],"Background:":[1],"Microsatellite":[2],"instability-high":[3],"(MSI-H)":[4],"metastatic":[5],"colorectal":[6],"cancer":[7,96],"(mCRC)":[8],"patients":[9],"who":[10],"have":[11,14],"failed":[12],"chemotherapy":[13,82],"shown":[15],"response":[16],"to":[17,30,61,80,129,154,174,183,198,223],"checkpoint":[18,210],"blockade.":[19],"We":[20],"investigate":[21],"optimal":[22],"third-line":[23,224],"treatment":[24,178],"in":[25,195,235],"MSI-H":[26,58,220],"mCRC":[27,59,221],"with":[28,57,71,136,168,193],"regard":[29],"overall":[31,215],"survival,":[32],"quality":[33],"of":[34,51,64,231,240],"life":[35,119],"years":[36],"gained":[37],"(QALYs),":[38],"and":[39,73,111,122,150,160,176,208,217],"cost-effectiveness.":[40],"Methods:":[41],"A":[42],"Markov":[43],"Model":[44],"was":[45,132,138,170,180],"created":[46],"for":[47,219],"a":[48,52],"base":[49],"case":[50],"57":[53],"year":[54],"old":[55],"man":[56],"refractory":[60],"two":[62],"lines":[63],"chemotherapy.":[65],"Treatments":[66],"compared":[67,153,173,182,222],"were":[68,105,115,227],"nivolumab,":[69],"nivolumab":[70,155,167,175,188,232,242,245],"ipilimumab,":[72],"trifluridine/tipiracil.":[74,184],"Patients":[75],"could":[76,190,243],"remain":[77],"stable,":[78],"progress":[79],"fourth-line":[81],"or":[83,93,117],"palliative":[84],"care,":[85],"experience":[86],"drug":[87,196,236],"toxicity,":[88],"die":[89,94],"from":[90,95],"age/sex":[91],"mortality,":[92],"over":[97],"their":[98],"simulated":[99],"lifetimes.":[100],"Transitions":[101],"between":[102],"health":[103],"states":[104],"based":[106],"on":[107],"the":[108,139],"CheckMate":[109],"142":[110],"RECOURSE":[112],"trials.":[113],"Outcomes":[114],"survival":[116,216],"unadjusted":[118,147],"years,":[120],"QALYs,":[121],"incremental":[123],"cost-effectiveness":[124],"ratios":[125],"(ICERs).":[126],"The":[127],"willingness":[128],"pay":[130],"threshold":[131],"$100,000/QALY.":[133],"Results:":[134],"Nivolumab":[135],"ipilimumab":[137,169],"most":[140],"effective":[141],"strategy":[142,179],"as":[143],"it":[144],"yielded":[145],"more":[146],"life-years":[148],"(4.24)":[149],"QALYs":[151,218],"(2.53)":[152],"(3.95":[156],"LY,":[157,163],"2.33":[158],"QALYs)":[159],"trifluridine/tipiracil":[161],"(0.74":[162],"0.07":[164],"QALYs).":[165],"However,":[166],"not":[171,228],"cost-effective":[172,181,192,229],"neither":[177],"Sensitivity":[185],"analysis":[186,203],"found":[187],"monotherapy":[189,246],"be":[191],"decrease":[194],"cost":[197],"$2000/dose.":[199],"Conclusions:":[200],"Our":[201],"modeling":[202],"finds":[204],"that":[205],"both":[206],"single":[207],"dual":[209],"blockade":[211],"yield":[212],"significantly":[213],"increased":[214],"chemotherapy,":[225],"but":[226],"because":[230],"cost.":[233],"Decreases":[234],"pricing":[237],"and/or":[238],"duration":[239],"maintenance":[241],"make":[244],"cost-effective.":[247],"[Table:":[248],"see":[249],"text]":[250]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2019-01-11T00:00:00"}